As the Mississippi Senate considers a bill that would ban the use of pharmaceuticals and sex reassignment surgery for minors who think they are experiencing gender dysphoria, the state’s leading health coverage company has taken a firm stance against the procedures.
The Mississippi Division of Medicaid said it agreed with a report from the Florida Agency for Health Care Administration (pdf) concluding that there is a lack of conclusive evidence to support medical intervention for gender dysphoria in children and adolescents.
